메뉴 건너뛰기




Volumn 23, Issue 2, 2015, Pages 196-201

Clinical effects of quadruple therapy based on antimicrobial susceptibility testing in treatment of helicobacter pylori associated upper digestive tract diseases

Author keywords

Helicobacter pylori infection; Individualized Treatment; Susceptibility; Upper digestive tract diseases

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; ESOMEPRAZOLE; FURAZOLIDONE; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN DERIVATIVE;

EID: 84922471256     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v23.i2.196     Document Type: Article
Times cited : (7)

References (3)
  • 2
    • 44949243126 scopus 로고    scopus 로고
    • New concepts of resistance in the treatment of Helicobacter pylori infections
    • [PMID:18446147
    • Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 321-331 [PMID:18446147 DOI: 10.1038/ncpgasthep1138]
    • (2008) Nat Clin Pract Gastroenterol Hepatol , vol.5 , pp. 321-331
    • Graham, D.Y.1    Shiotani, A.2
  • 3
    • 79952198319 scopus 로고    scopus 로고
    • Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai
    • [PMID: 20976850]
    • Sun QJ, Liang X, Zheng Q, Gu WQ, Liu WZ, Xiao SD, Lu H. Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol 2010; 16: 5118-5121 [PMID: 20976850]
    • (2010) World J Gastroenterol , vol.16 , pp. 5118-5121
    • Sun, Q.J.1    Liang, X.2    Zheng, Q.3    Gu, W.Q.4    Liu, W.Z.5    Xiao, S.D.6    Lu, H.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.